As a result, the specific prevalence of sarcopenia differs according to the diagnostic criteria. In general, the target population consisted of individuals aged 65 years and older, but the cutoff values varied by ethnic group or population. Here, we review the etiology of and diagnostic criteria for sarcopenia. Even without any weight change, body composition can change with aging . The World Health Organization predicted that the population of people over 60 years of age will reach approximately two billion by 2050. This study demonstrated that these effects are mediated through an AR-dependent mechanism, because an AR antagonist blocked the actions of testosterone or DHT. While other anabolic, such as DHEA, oxandrolone, and SARMs appear to be promising agents in sarcopenia treatment, further research is required before recommendations regarding their pharmacological use can be developed. The development of "state-of-the-art" testosterone treatments has called for wide-scale longitudinal population studies to determine their profile. A great concern over the previous decade was that androgen supplementation increased risk of cardiovascular and prostate events. You won't have the body of a young adult, but strength training can, for example, give an 85-year-old the muscles and strength expected in a typical 65-year-old. You'll see improvements in strength, followed by bigger muscles if you stick to an effective workout for several months. While sarcopenia can have serious consequences, you can regain some of your strength with exercise and a good diet. You're likely to get the best results when you combine a protein-rich diet with strength training. Many older adults with sarcopenia consume less protein and fewer calories than recommended. As you work on strength, it's also a good idea to include aerobic exercise, such as walking, to build your endurance and improve overall health, and balance exercises, to reduce your risk of falling. Loss of muscle mass and function is correlated with high morbidity and mortality owing to an increased risk of frailty and falling. The aging process is connected to changes in body composition involving decreased muscle mass and increased body fat, with or without body weight change . Testosterone treatment has been reported to have beneficial effects on muscle mass and function, but the results have been inconsistent. A variety of imaging tests can be used to measure muscle mass and confirm sarcopenia. Diets with a lot of ultra-processed foods — manufactured products with high levels of sugar, salt, additives, and unhealthy fats — also have been linked to low muscle mass. Premenopausal women experience decreases in androgens, including testosterone, with increased age (55). In human studies, testosterone treatment increased type I muscle fibers in both low and high concentrations, and type II muscle fibers in high concentrations 27,28. They recommended estimating muscle function based on gait speed and grip strength and muscle mass according to appendicular skeletal muscle mass adjusted by height squared (Fig. 1). As these medical conditions increase social and healthcare costs, both the perceived importance of muscle mass and function and overall interest in the topic have been increasing. There are a number of potential sources of muscle stem cells for cell replacement therapies such as bone marrow-derived stem cells, hematopoietic stem cells, and MSCs. A decline in homeostatic and regenerative capacity occurs in aging, where a degenerative change in stem cells homeostasis has been postulated. Therefore, in older men with sarcopenia a program of physical exercise together with TRT emerges as a promising therapeutic alternative. Treatment with one or more of the numerous other SARMs currently under study may emerge as therapeutic alternatives to androgen agonist therapy.